Drugs / Milk Powder
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00732654 | Aug 2008 → Jun 2010 | food allergy | Johns Hopkins University | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01157117 | Aug 2010 → Jan 2015 | food allergy | Hugh A Sampson, MD | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Milk Powder | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00732654 ↗ |
| Route | Oral | “given orally” NCT00732654 ↗ |